| Dementia with Lewy bodies: an update and outlook TF Outeiro, DJ Koss, D Erskine, L Walker, M Kurzawa-Akanbi, D Burn, ... Molecular neurodegeneration 14, 1-18, 2019 | 334 | 2019 |
| Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease KE McAleese, L Walker, S Graham, ELJ Moya, M Johnson, D Erskine, ... Acta neuropathologica 134, 459-473, 2017 | 244 | 2017 |
| TDP‐43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing KE McAleese, L Walker, D Erskine, AJ Thomas, IG McKeith, J Attems Brain pathology 27 (4), 472-479, 2017 | 227 | 2017 |
| Parkinson’s disease biomarkers based on α‐synuclein M Fayyad, S Salim, N Majbour, D Erskine, E Stoops, B Mollenhauer, ... Journal of neurochemistry 150 (5), 626-636, 2019 | 144 | 2019 |
| α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity SS Ghanem, NK Majbour, NN Vaikath, MT Ardah, D Erskine, NM Jensen, ... Proceedings of the National Academy of Sciences 119 (15), e2109617119, 2022 | 84 | 2022 |
| Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations AA Khundakar, PS Hanson, D Erskine, NZ Lax, J Roscamp, E Karyka, ... Acta neuropathologica communications 4, 1-18, 2016 | 79 | 2016 |
| Antibodies against alpha‐synuclein: tools and therapies NN Vaikath, I Hmila, V Gupta, D Erskine, M Ingelsson, OMA El‐Agnaf Journal of Neurochemistry 150 (5), 612-625, 2019 | 66 | 2019 |
| Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders D Erskine, JP Taylor, G Bakker, AJH Brown, T Tasker, PJ Nathan Drug discovery today 24 (12), 2307-2314, 2019 | 49 | 2019 |
| Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies DJ Koss, D Erskine, A Porter, P Palmoski, H Menon, OGJ Todd, M Leite, ... Acta Neuropathologica Communications 10 (1), 98, 2022 | 40 | 2022 |
| Regional levels of physiological α-synuclein are directly associated with Lewy body pathology D Erskine, L Patterson, A Alexandris, PS Hanson, IG McKeith, J Attems, ... Acta neuropathologica 135, 153-154, 2018 | 40 | 2018 |
| Neuronal loss and Α-synuclein pathology in the superior colliculus and its relationship to visual hallucinations in dementia with Lewy bodies D Erskine, AJ Thomas, JP Taylor, MA Savage, J Attems, IG McKeith, ... The American Journal of Geriatric Psychiatry 25 (6), 595-604, 2017 | 40 | 2017 |
| Forecasting stroke-like episodes and outcomes in mitochondrial disease YS Ng, NZ Lax, AP Blain, D Erskine, MR Baker, T Polvikoski, RH Thomas, ... Brain 145 (2), 542-554, 2022 | 39 | 2022 |
| Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies D Erskine, AJ Thomas, J Attems, JP Taylor, IG McKeith, CM Morris, ... Movement Disorders 32 (3), 414-422, 2017 | 39 | 2017 |
| Changes to the lateral geniculate nucleus in A lzheimer's disease but not dementia with L ewy bodies D Erskine, JP Taylor, MJ Firbank, L Patterson, M Onofrj, JT O'Brien, ... Neuropathology and applied neurobiology 42 (4), 366-376, 2016 | 39 | 2016 |
| Inflammation in dementia with Lewy bodies J Amin, D Erskine, PC Donaghy, A Surendranathan, P Swann, AP Kunicki, ... Neurobiology of disease 168, 105698, 2022 | 36 | 2022 |
| Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease KE McAleese, S Graham, M Dey, L Walker, D Erskine, M Johnson, ... Brain Pathology 29 (3), 414-424, 2019 | 36 | 2019 |
| Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders D Erskine, D Koss, VI Korolchuk, TF Outeiro, J Attems, I McKeith Acta Neuropathologica 141, 511-526, 2021 | 35 | 2021 |
| Heterogeneity in α‐synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease NN Vaikath, D Erskine, CM Morris, NK Majbour, K Vekrellis, JY Li, ... Neuropathology and applied neurobiology 45 (6), 597-608, 2019 | 33 | 2019 |
| Disease-associated α-synuclein aggregates as biomarkers of Parkinson disease clinical stage N Majbour, J Aasly, I Abdi, S Ghanem, D Erskine, W van de Berg, ... Neurology 99 (21), e2417-e2427, 2022 | 28 | 2022 |
| Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies D Erskine, J Ding, AJ Thomas, A Kaganovich, AA Khundakar, PS Hanson, ... Movement Disorders 33 (6), 982-991, 2018 | 28 | 2018 |
